Traitement en cours

Veuillez attendre...

PATENTSCOPE sera indisponible durant quelques heures pour des raisons de maintenance le dimanche 05.04.2020 à 10:00 AM CEST
Paramétrages

Paramétrages

1. WO2003008391 - COMPOSES AZOLE EN TANT QU'AGENTS ANTIFONGIQUES

Numéro de publication WO/2003/008391
Date de publication 30.01.2003
N° de la demande internationale PCT/IB2002/002662
Date du dépôt international 08.07.2002
Demande présentée en vertu du Chapitre 2 04.02.2003
CIB
C07D 521/00 2006.01
CCHIMIE; MÉTALLURGIE
07CHIMIE ORGANIQUE
DCOMPOSÉS HÉTÉROCYCLIQUES
521Composés hétérocycliques contenant des hétérocycles non spécifiés
CPC
C07D 231/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
231Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
02not condensed with other rings
10having two or three double bonds between ring members or between ring members and non-ring members
12with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D 233/56
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
233Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
54having two double bonds between ring members or between ring members and non-ring members
56with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
C07D 249/08
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
249Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
02not condensed with other rings
081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
C07D 249/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
249Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
02not condensed with other rings
081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
10with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
12Oxygen or sulfur atoms
Déposants
  • RANBAXY LABORATORIES LIMITED [IN/IN]; 19 Nehru Place New Delhi 110 019, IN (AllExceptUS)
  • SALMAN, Mohammad [IN/IN]; IN (UsOnly)
  • KATOCH, Rita [IN/IN]; IN (UsOnly)
  • VERMA, Ashwani, Kumar [IN/IN]; IN (UsOnly)
  • SATTIGERI, Jitendra [IN/IN]; IN (UsOnly)
  • RATTAN, Ashok [IN/IN]; IN (UsOnly)
Inventeurs
  • SALMAN, Mohammad; IN
  • KATOCH, Rita; IN
  • VERMA, Ashwani, Kumar; IN
  • SATTIGERI, Jitendra; IN
  • RATTAN, Ashok; IN
Mandataires
  • DESHMUKH, Jayadeep, R.; Ranbaxy Laboratories Limited Suite 2100 600 College Road East Princeton, NJ 08540, US
Données relatives à la priorité
778/DEL/200119.07.2001IN
PCT/IB01/0262021.12.2001IB
Langue de publication anglais (EN)
Langue de dépôt anglais (EN)
États désignés
Titre
(EN) AZOLE COMPOUNDS AS ANTI-FUNGAL AGENTS
(FR) COMPOSES AZOLE EN TANT QU'AGENTS ANTIFONGIQUES
Abrégé
(EN)
The present invention relates to the derivatives of specially substituted azole compounds which have improved antifungal activity as compared with presently available agents in this class and the processes for the preparation thereof. This invention also relates to pharmaceutical preparations containing the compounds of the present invention and their use in treating and/or preventing the fungal infections in mammals, preferably humans.
(FR)
L'invention concerne des dérivés de composés azole spécialement substitués possédant une activité antifongique améliorée en comparaison des agents actuellement disponibles dans cette classe, ainsi que des procédés de préparation associés. L'invention concerne aussi des préparations pharmaceutiques contenant les composés de l'invention ainsi que leur utilisation dans le traitement et/ou la prévention d'infections fongiques chez les mammifères, en particulier chez l'homme.
Également publié en tant que
Dernières données bibliographiques dont dispose le Bureau international